ES410104A1 - Procedimiento para producir un compuesto de prostaglandina. - Google Patents
Procedimiento para producir un compuesto de prostaglandina.Info
- Publication number
- ES410104A1 ES410104A1 ES410104A ES410104A ES410104A1 ES 410104 A1 ES410104 A1 ES 410104A1 ES 410104 A ES410104 A ES 410104A ES 410104 A ES410104 A ES 410104A ES 410104 A1 ES410104 A1 ES 410104A1
- Authority
- ES
- Spain
- Prior art keywords
- prostaglandin
- new
- derivatives
- dihydro
- f1alpha
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229940094443 oxytocics prostaglandins Drugs 0.000 title abstract 3
- 150000003180 prostaglandins Chemical class 0.000 title abstract 3
- DZUXGQBLFALXCR-UHFFFAOYSA-N (+)-(9alpha,11alpha,13E,15S)-9,11,15-trihydroxyprost-13-en-1-oic acid Natural products CCCCCC(O)C=CC1C(O)CC(O)C1CCCCCCC(O)=O DZUXGQBLFALXCR-UHFFFAOYSA-N 0.000 abstract 3
- DZUXGQBLFALXCR-CDIPTNKSSA-N prostaglandin F1alpha Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)C[C@H](O)[C@@H]1CCCCCCC(O)=O DZUXGQBLFALXCR-CDIPTNKSSA-N 0.000 abstract 3
- PXGPLTODNUVGFL-BRIYLRKRSA-N (E,Z)-(1R,2R,3R,5S)-7-(3,5-Dihydroxy-2-((3S)-(3-hydroxy-1-octenyl))cyclopentyl)-5-heptenoic acid Chemical compound CCCCC[C@H](O)C=C[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC=CCCCC(O)=O PXGPLTODNUVGFL-BRIYLRKRSA-N 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- SAKGBZWJAIABSY-SAMSIYEGSA-N prostaglandin F3alpha Chemical compound CC\C=C/C[C@H](O)\C=C\[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\C=C/CCCC(O)=O SAKGBZWJAIABSY-SAMSIYEGSA-N 0.000 abstract 2
- 230000002997 prostaglandinlike Effects 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- PXGPLTODNUVGFL-UHFFFAOYSA-N prostaglandin F2alpha Natural products CCCCCC(O)C=CC1C(O)CC(O)C1CC=CCCCC(O)=O PXGPLTODNUVGFL-UHFFFAOYSA-N 0.000 abstract 1
- WGJJROVFWIXTPA-OALUTQOASA-N prostanoic acid Chemical class CCCCCCCC[C@H]1CCC[C@@H]1CCCCCCC(O)=O WGJJROVFWIXTPA-OALUTQOASA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Esta invención se refiera a composiciones de materia y a métodos para su producción. Los distintos aspectos de esta invención se refieren a nuevos derivados de algunas de las prostaglandinas conocidas, por ejemplo, prostaglandina F1alfa(PGF1alfa), prostaglandina F2alfa, (PGF2alfa), prostaglandina F3alfa(PGF3alfa), dihidro prostaglandina F1alfa(dihidro-PFG1alfa), y sus 15beta epímeros, y sus racematos, y a nuevos métodos para producir estos nuevos derivados tipo prostaglandina. En particular, los nuevos derivados tipo prostaglandina de esta invención están carboxiacilados en la posición C-15 Cada una de las prostaglandinas conocidas antes mencionadas es un derivado del ácido prostanoico que tiene la siguiente estructura y numeración de átomos
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21447271A | 1971-12-30 | 1971-12-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES410104A1 true ES410104A1 (es) | 1975-12-16 |
Family
ID=22799199
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES410104A Expired ES410104A1 (es) | 1971-12-30 | 1972-12-28 | Procedimiento para producir un compuesto de prostaglandina. |
Country Status (14)
| Country | Link |
|---|---|
| JP (1) | JPS4875548A (es) |
| BE (1) | BE793534A (es) |
| CA (1) | CA978940A (es) |
| CH (1) | CH583191A5 (es) |
| DE (1) | DE2262608A1 (es) |
| DK (1) | DK135212B (es) |
| ES (1) | ES410104A1 (es) |
| FR (1) | FR2166194B1 (es) |
| GB (2) | GB1389069A (es) |
| HU (1) | HU166953B (es) |
| IL (2) | IL40970A (es) |
| NL (1) | NL7217579A (es) |
| SE (1) | SE411899B (es) |
| ZA (1) | ZA728737B (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4001306A (en) * | 1971-12-30 | 1977-01-04 | The Upjohn Company | Prostaglandin F.sub.α 15-monoacrylates |
| CA2014038A1 (en) * | 1989-05-25 | 1990-11-25 | Charles Gluchowski | Intraocular pressure reducing 15-acyl prostaglandins |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE391714B (sv) * | 1970-09-11 | 1977-02-28 | Upjohn Co | Forfarande for framstellning av prostaglandiner av typ pge?712 med foreningar av typ pga?712 som utgangsforeningar |
-
0
- BE BE793534D patent/BE793534A/xx unknown
-
1972
- 1972-11-24 CA CA157,431A patent/CA978940A/en not_active Expired
- 1972-11-28 GB GB5494872A patent/GB1389069A/en not_active Expired
- 1972-11-28 GB GB3201074A patent/GB1389070A/en not_active Expired
- 1972-11-30 IL IL40970A patent/IL40970A/en unknown
- 1972-11-30 IL IL47174A patent/IL47174A/en unknown
- 1972-12-11 JP JP47123522A patent/JPS4875548A/ja active Pending
- 1972-12-11 ZA ZA728737A patent/ZA728737B/xx unknown
- 1972-12-13 CH CH1813872A patent/CH583191A5/xx not_active IP Right Cessation
- 1972-12-21 DE DE2262608A patent/DE2262608A1/de active Pending
- 1972-12-22 NL NL7217579A patent/NL7217579A/xx not_active Application Discontinuation
- 1972-12-27 HU HUUO84A patent/HU166953B/hu unknown
- 1972-12-27 SE SE7216988A patent/SE411899B/xx unknown
- 1972-12-28 ES ES410104A patent/ES410104A1/es not_active Expired
- 1972-12-29 DK DK655272AA patent/DK135212B/da unknown
- 1972-12-29 FR FR7246986A patent/FR2166194B1/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| BE793534A (fr) | 1973-06-29 |
| FR2166194A1 (es) | 1973-08-10 |
| NL7217579A (es) | 1973-07-03 |
| CA978940A (en) | 1975-12-02 |
| HU166953B (es) | 1975-06-28 |
| DK135212C (es) | 1977-09-05 |
| ZA728737B (en) | 1973-09-26 |
| IL47174A (en) | 1976-03-31 |
| DE2262608A1 (de) | 1973-07-12 |
| CH583191A5 (es) | 1976-12-31 |
| SE411899B (sv) | 1980-02-11 |
| IL40970A (en) | 1976-03-31 |
| IL40970A0 (en) | 1973-01-30 |
| GB1389069A (en) | 1975-04-03 |
| FR2166194B1 (es) | 1977-01-28 |
| GB1389070A (en) | 1975-04-03 |
| DK135212B (da) | 1977-03-21 |
| JPS4875548A (es) | 1973-10-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES428889A1 (es) | Procedimiento de preparacion de derivados de acido prosta- noico. | |
| SE409862B (sv) | Sett att framstella ett propanolaminderivat, som er blockerare av beta-adrenerga receptorer | |
| US4201873A (en) | 9-Deoxy-9,10-didehydro-PGD2 analogs | |
| ES419672A1 (es) | Un procedimiento para la preparacion de cetonas cicloalifa-ticas. | |
| ES410104A1 (es) | Procedimiento para producir un compuesto de prostaglandina. | |
| SE7705945L (sv) | Cyklopentanderivat | |
| GB1484591A (en) | Prostaglandin compositions | |
| ES442887A1 (es) | Un procedimiento para la preparacion de un nuevo compuesto d-6-metil-ergolina 8-sustituida. | |
| ES438595A1 (es) | Un metodo para preparar derivados de yodo-alquenilo susti- tuidos en la posicion 3. | |
| GB1424417A (en) | Prostaglandin intermediates and their preparation | |
| ES448979A1 (es) | Procedimiento para la preparacion de nuevas pirrolidinas analogas a prostaglandinas. | |
| ES437100A1 (es) | Un procedimiento para la preparacion de d-homoesteroides. | |
| ES402263A1 (es) | Un metodo para sintetizar nuevos analogos de prostaglandi- na. | |
| ES439449A0 (es) | Procedimiento para preparar derivados del metional | |
| ES427198A1 (es) | Procedimiento para la preparacion de derivados de ciclopen-tano. | |
| ES462849A1 (es) | Un procedimiento para la preparacion de nuevos derivados de 3,5-diona-4,4-dimetil-pirrolidina. | |
| DE2963017D1 (en) | Prostane derivatives, processes for their preparation and their pharmaceutical compositions | |
| FR2326184A1 (fr) | Analogues de prostaglandines et leur preparation | |
| ES401729A1 (es) | Procedimiento para la obtencion de un biciclohepteno - 7 - sin - carbaldehido. | |
| ES411984A1 (es) | Procedimiento para la preparacion de compuestos isoprenoi- des aciclicos que contienen nitrogeno. | |
| GB1202010A (en) | Prostaglandins and the manufacture thereof | |
| ES402328A1 (es) | Procedimiento para preparar 4-hidroxibenzodio-xol. | |
| ES428047A1 (es) | Un procedimiento para la preparacion de nuevos derivados de prostaglandina. | |
| ES386714A1 (es) | Procedimiento para la preparacion de nuevos derivados de tiepina. | |
| GB1546442A (en) | 15-(1,3-benzodioxan-2-yl)-16,17,18,19,20-pentanor prostanoic acid derivatives and process for their manufacture |